Yuji Shimamoto
Hanno Research Center
Taiho Pharmaceutical Co.
Ltd., Hanno
Saitama 357-8527
Japan
Name/email consistency: high
- Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106. Shimamoto, Y., Kazuno, H., Murakami, Y., Azuma, A., Koizumi, K., Matsuda, A., Sasaki, T., Fukushima, M. Jpn. J. Cancer Res. (2002)
- Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2. Shimamoto, Y., Koizumi, K., Okabe, H., Kazuno, H., Murakami, Y., Nakagawa, F., Matsuda, A., Sasaki, T., Fukushima, M. Jpn. J. Cancer Res. (2002)